In addition, Fernández-Aceñero et al. correlate the expression of TG2 in the stroma, which is required in CRC metastatic progression, with a high risk of relapse, while its epithelial expression was associated with poor overall survival [84]. The gene discussed is TGM2; the disease is colorectal carcinoma.